Cargando…
Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration
Age-related macular degeneration (AMD) is now considered an important and leading cause of blindness among elderly patients in developed and developing countries. AMD has two forms, dry and wet; both can lead to visual loss. However, occurrence of subfoveal choroidal neovascular (CNV) membrane in th...
Autores principales: | Gopal, Lekha, Sharma, Tarun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635983/ https://www.ncbi.nlm.nih.gov/pubmed/17951899 |
Ejemplares similares
-
Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2008) -
Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema
por: Choi, Young Jae, et al.
Publicado: (2006) -
Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema
por: Zakaria, Yousra Gamal, et al.
Publicado: (2022) -
Intraocular Pressure Following Intravitreal Injection of Triamcinolone Acetonide
por: Ansari, Ejaz A, et al.
Publicado: (2008) -
Vitrectomy Combined with Intravitreal Triamcinolone Acetonide Injection and Macular Laser Photocoagulation for Nontractional Diabetic Macular Edema
por: Kim, Jae Hui, et al.
Publicado: (2013)